Poly Medicure Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Poly Medicure Ltd is ₹ 1447 as of 30 Oct 15:30 . The P/E Ratio of Poly Medicure Ltd changed from 57.7 on March 2021 to 37.5 on March 2026 . This represents a CAGR of -6.93% over 6 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 42.2 on March 2021 to 34.2 on March 2026 . This represents a CAGR of -3.44% over 6 years The Market Cap of Poly Medicure Ltd changed from ₹ 7839 crore on March 2021 to ₹ 12069 crore on March 2026 . This represents a CAGR of 7.46% over 6 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 4774 crore on March 2021 to ₹ 5566 crore on March 2026 . This represents a CAGR of 2.59% over 6 years The revenue of Poly Medicure Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 560.34 crore. This represent the decline of -100% The revenue of Thyrocare Technologies Ltd for the Sep '26 is ₹ 275.24 crore as compare to the Jun '26 revenue of ₹ 244.88 crore. This represent the growth of 12.4% The ebitda of Poly Medicure Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 160.06 crore. This represent the decline of -100% The ebitda of Thyrocare Technologies Ltd for the Sep '26 is ₹ 48.74 crore as compare to the Jun '26 ebitda of ₹ 82.13 crore. This represent the decline of -40.66% The net profit of Poly Medicure Ltd changed from ₹ 74.04 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 15.22 crore over 10 quarters. This represents a CAGR of -16.57% The Dividend Payout of Poly Medicure Ltd changed from 18.51 % on March 2021 to 10.56 % on March 2026 . This represents a CAGR of -8.93% over 6 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .

About Poly Medicure Ltd

Poly Medicure Limited was incorporated on March 30, 1995.
The Company is a manufacturer/producer of Medical Devices.
It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others. The Company's product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Poly Medicure Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Poly Medicure Ltd or Thyrocare Technologies Ltd?

Market cap of Poly Medicure Ltd is 14,676 Cr while Market cap of Thyrocare Technologies Ltd is 7,273 Cr

What are the key factors driving the stock performance of Poly Medicure Ltd and Thyrocare Technologies Ltd?

The stock performance of Poly Medicure Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Poly Medicure Ltd and Thyrocare Technologies Ltd?

As of October 31, 2026, the Poly Medicure Ltd stock price is INR ₹1447.9. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹457.0.

How do dividend payouts of Poly Medicure Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Poly Medicure Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.